← All trials
NCT04798235
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 12, 2021
- Primary completion
- Mar 12, 2023
- Completion date
- Mar 12, 2027
- First posted
- Mar 15, 2021
- Last posted
- Aug 4, 2021
- Enrollment
- 6
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Queen's University, BelfastLead sponsor
- Queen's University, BelfastSponsor investigator
- Queen's University, BelfastOverall official - principal investigator
- Canadian Glycomics Network (GlycoNet)Collaborator
- Taysha Gene Therapies, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.